Navigation Links
More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Line Therapy
Date:4/7/2008

1-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
5. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
8. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
9. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
10. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
11. New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Thomson Reuters today announced ... first drug pipeline database to fully integrate detailed ... anticipated new content is being provided to all ... Thomson Pharma will offer drug related ... conferences, and other sources across all therapeutic areas. ...
(Date:12/14/2009)... THOUSAND OAKS, Calif., Dec. 14 Array ... Inc.(Nasdaq: AMGN ) today announced that they ... rights to Array,s small-molecule glucokinase activator program, including ... clinical trial in patients with Type 2 diabetes. ... agreement, Array will receive an upfront payment of ...
(Date:12/14/2009)... Kennedy Joins with State Biotech Leaders to ... Research and Development while Boosting Rhode Island,s ... ,, PROVIDENCE, R.I., Dec. 14 ... in research, medicine and biotechnology gathered today ... discuss the importance of medical innovation in ...
(Date:12/14/2009)... Dec. 14 Lionbridge (Nasdaq: ... signed a new, three-year master services agreement ... products and services that serve patients in ... will become the sole provider for translation ... regulatory, marketing, training, human resources, legal, and ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3
... , announced today they have signed a distribution ... independent distributor of advanced clinical in-vitro diagnostic products. ... last Wednesday with Promega. , ,"Both companies share ... provide strong long-term customer value. Inter Medico's highly ...
... faculty at the University of Wisconsin-Eau Claire are ... to work on research relating to materials science ... to assist local industries. , ,UW-Eau Claires newly ... collaboration among science faculty across disciplines, promote interactions ...
... economists in the Unites States are concerned with the increasing ... down and begin the process of leveling the playing field. ... , ,As developing nations rush to play catch-up with more ... to friends in high places, and not necessarily for sound ...
Other Biology Technology:UW-Eau Claire creates Materials Science Center 2UW-Eau Claire creates Materials Science Center 3How do you level the playing field with China? 2How do you level the playing field with China? 3
(Date:12/14/2009)... December 10, 2009If you are spending the holidays with ... whether you would be better off with another family, ... , A research team from McMaster University and the ... cichlids, a species that lives in groups, members make ... results appear in the current issue of Biology ...
(Date:12/14/2009)... thought of tool use as a defining feature of humans. ... primates, along with birds and an array of other mammals. ... Current Biology , a Cell Press publication, adds an octopus ... octopus under study manages a behavioral trick that the researchers ... over stacked, upright coconut shell "bowls," makes its eight arms ...
(Date:12/14/2009)... 14 MODA Technology Partners, a global ... and product testing for the Pharmaceutical industry, today ... company,s third generation mobile data acquisition platform. The ... further automate their regulated manufacturing processes. ,, ... Fully-Configurable Test Methods: Each test ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 1Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 2Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 3Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 4Carmel Pharma Introduces PhaSeal Secondary Set 28C60 29 60467 1Carmel Pharma Introduces PhaSeal Secondary Set 28C60 29 60467 2Study shows that sleep disturbances improve after retirement 60463 1Study shows that sleep disturbances improve after retirement 60463 2Study shows that sleep disturbances improve after retirement 60463 3Study shows that sleep disturbances improve after retirement 60463 4Study shows that sleep disturbances improve after retirement 60463 5
... with the potential to cause disease in plants or ... the Americas by hitchhiking on microscopic dust particles kicked ... presented today at the 106th General Meeting of the ... study presents evidence of early summer survival and transport ...
... growers were among the first farmers worldwide to plant ... profits they have reaped for several years by saving ... as reported by Cornell University researchers at the American ... Calif., today (July 25), is that other pests are ...
... Too much sun ?for plants as well as people ... the botanical equivalent of "lobster tans," plants have developed ... like sunscreen to ward off the sun's harmful rays. ... this process of photoprotection, but the question has been, ...
Other Biology News:Microbes hitchhike across Atlantic on desert dust 2Bt cotton in China fails to reap profit after seven years 2How plants avoid feeling the burn 2How plants avoid feeling the burn 3How plants avoid feeling the burn 4
...
...
... Class II safety cabinets Heraeus HERAsafe KS convince ... design. ,The new frameless slanted window does ... The new front window design makes it easy ... work aperture with a height of more than ...
... Thermo has recently launched a custom ... RNA (siRNA). Thermos siRNA molecules are: ... with 2 DNA bases overhang at ... Delivered fully deprotected and ready-to-use. ...
Biology Products: